SNORD126 is reported to be up-regulated and activates the PI3K-AKT pathway to promote tumor growth (60), and SNORD50A and SNORD50B function as tumor suppressors via repressing the activity of K-Ras pathway (61). The gene discussed is KRAS; the disease is neoplasm.